There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for…
[Read More]
October 01 at 10:30 am
September 30 at 3:12 pm
Is Lantheus Holdings, Inc. (NASDAQ:LNTH) Expensive For A Reason? A Look At Its Intrinsic Value
Today we’ll do a simple run through of a valuation method used to estimate the attractiveness of Lantheus Holdings, Inc. (NASDAQ:LNTH) as an investment opportunity…
[Read More]
September 30 at 11:21 am
10 Best Multibagger Stocks to Buy Now
In this article, we discuss the 10 best multibagger stocks to buy now. If you want to skip our discussion on the macroeconomic situation, go…
[Read More]
September 30 at 8:38 am
OpGen Announces $3.38 Million Registered Direct Offering
OpGen, Inc.ROCKVILLE, Md., Sept. 30, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of…
[Read More]
September 29 at 4:05 pm
ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
ANN ARBOR, Mich., September 29, 2022–(BUSINESS WIRE)–ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS®), announces an…
[Read More]
September 29 at 9:00 am
Motus GI Named a Sole Source Supplier with U.S. Department of Veteran Affairs
Motus GI Holdings, Inc.Multiple contracts with VA medical centers already executed for Pure-Vu EVS under the sole source supplier designation, with additional centers under evaluationApproximately…
[Read More]
September 29 at 8:30 am
T2 Biosystems Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million
T2 Biosystems, Inc.Advances U.S. Clinical Trials and FDA Submission for T2Resistance and T2Biothreat PanelsLEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a…
[Read More]
September 29 at 8:00 am
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
Genetic Technologies LtdMELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests…
[Read More]
September 29 at 7:01 am
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
CareDx Top-Tier Sponsor for Heart Failure Society of America Annual Scientific MeetingBRISBANE, Calif., September 29, 2022–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused…
[Read More]
September 28 at 10:28 am
OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test
ReutersByteDance plans for maximum of nine board directors -sourceShareholders approved the move at an investor meeting on Tuesday, boosting the figure from the previous maximum…
[Read More]
September 28 at 9:00 am
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
Myriad Genetics, Inc.SALT LAKE CITY, Sept. 28, 2022 (GLOBE NEWSWIRE) — Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results…
[Read More]
September 28 at 7:05 am
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test
OraSure Technologies, Inc.BETHLEHEM, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and…
[Read More]